Diabetes is life long affliction that causes a person’s blood sugar level to become too high. With the two main types of diabetes, type 2 is far more common. Around 90% of all adults with diabetes have type 2.
Types
Type 2 is where the body is not creating enough insulin or the body is not reacting correctly to the insulin. This type usually requires the managing of medication, finding the right medication for each person can take time. Also many of the medications have side affects.
Type 1 is when the level of glucose in blood to be too high. This happens when the body isn’t producing enough of the hormone insulin which controls the levels of glucose in blood.
Both types are manageable with the correct advice and medication.
There are articles below that explore the condition in many different ways. Covering new research and evidence.
University of Bristol researchers have discovered a VEGF-C gene therapy that protects the kidneys and may prevent serious complications in people with type 1 diabetes.
Kristoffer From, CEO of Liva Healthcare and Simon Pickup, UK Managing Director at Liva Healthcare share their thoughts on why obesity is key to tackling the root cause of Type 2 diabetes
Candice Ward, Lead CDEP Educator from Cambridge Diabetes Education Programme (CDEP) details online diabetes competency training, including the importance of improving standards and reducing variation
A change of paradigm improves patients’ outcomes with diabetes & peripheral arterial disease, according to the Division of Angiology at the Medical University of Vienna
CEO of Liva Healthcare, Kristoffer From explains the emergence of personalised e-health care and asks if e-health can close the gap between doctors and diabetic patients
John J. Nolan, Stefano Del Prato, Juleen R. Zierath from the European Association for the Study of Diabetes e.V. present their approach to address the pandemic of diabetes in Europe today
A new initiative to prevent mental health problems arising in children with long-term physical conditions has been successfully piloted across Scotland
Long-term conditions, such as...
Philip Sherman, Mary-Jo Makarchuk and Keeley Rose at the Canadian Institutes of Health Research, highlight the need for research to inform successful obesity policies
Obesity...
Anssi Pulkkinen, director of wellbeing and health at Finnish funding agency Tekes, on the role of technology in securing sustainable healthcare for all
Technological development...
Although a small field in medicine, dermatological diseases are very frequent and span a wide range of illnesses such as allergies, inflammation (e.g. atopic...
Advertisements
Latest Academic Articles
The latest academic articles from key research stakeholders
